Media

Versitech Limited, the commercial arm of the University of Hong Kong (HKU), hosted the HKU Industry Forum 2025, titled "Therapeutics Insights: Bridging Academia, Industry, and Investments”, on HKU campus. The event convened a diverse group of researchers, industry leaders, and investors to delve into the latest advancements and challenges facing the therapeutic sector.

The forum served as a pivotal platform for exchanging innovative ideas and insights crucial for shaping the future of healthcare. Distinguished experts shared presentations on topics including cutting-edge university research, current market trends, and the vital role of academia-industry collaboration. These discussions showcased successful partnerships that have led to groundbreaking discoveries, demonstrating the transformative potential of collaborative efforts.

A panel discussion featured representatives from industry, academia, and the investment community, focusing on the challenges, resources, and strategies required to translate innovative discoveries into impactful products. The event also offered extensive networking opportunities, facilitating connections between research teams, industry players, and investors, and fostering relationships for future collaborations.

Professor Stephanie Ma, Associate Vice-President (Research and Innovation) at HKU, emphasised the importance of collaboration, stating, "The HKU Industry Forum brought together leading minds from academia and industry to explore the future of therapeutics, driving forward innovation through collaboration. This dynamic exchange of insights underscored the critical role of translational research in addressing global health challenges and shaping next-generation medical solutions."

The HKU Industry Forum 2025 underscored the University's commitment to advancing innovative research and highlighted the importance of interdisciplinary approaches in tackling complex health challenges. Participants left the event inspired and equipped to contribute to the evolving landscape of therapeutics.

For further information about the agenda, showcased teams and pitching sessions, please visit the event webpage: https://versitech.hku.hk/sc/event/hku-industry-forum-2025-therapeutics-insights.

About Versitech Limited
Versitech Limited is the commercial arm of HKU. Established in 1994 as a wholly-owned subsidiary of the University, it operates as a non-profit company with prominent business people on its Board of Management. Versitech negotiates, executes, and manages commercial business contracts and agreements on behalf of the University. To serve business and community needs, Versitech undertakes the commercialization of HKU innovations and technologies through licensing, the creation of start-ups or collaboration, and engages in contract research and consulting in conjunction with HKU researchers. Website: https://www.versitech.hku.hk.

Media enquiries
Please contact Versitech Limited by email at bd@versitech.hku.hk.